|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Allergic contact dermatitis |
|
irritant effect |
|
skin rash |
|
Dryness or peeling of skin |
|
feeling of warmth, mild stinging, or redness of skin |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Dermatitis, seborrheic |
|
Eczema |
|
>> Inflammation of skin, acute, or denuded skin, including sunburn |
|
|
ADULT DOSE:
|
|
Acne vulgaris-Topical, to the skin, as a 2.5 to 20% gel one or two times a day. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Acne vulgaris-Children up to 12 years of age: Safety and efficacy have not been established.
Children 12 years of age and over: See Usual adult and adolescent dose. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|